One in five pharmacies blocks access to key medication to treat addiction
New findings from the largest, most comprehensive study to date suggest opportunity to reduce stigma and roll back the national opioid epidemic
2021-04-26
(Press-News.org) One in five pharmacies refuse to dispense a key medication to treat addiction, according to new research.
The study, published in the journal Drug and Alcohol Dependence, was conducted by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy. Researchers called hundreds of pharmacies around the country to ask whether they would dispense Suboxone, also known as buprenorphine.
"Buprenorphine is a vital, lifesaving medication for people with opioid use disorder, but improving access has been a problem for a variety of reasons," said senior author Daniel Hartung, Pharm.D., M.P.H., professor in the College of Pharmacy. "Although anecdotes and smaller studies have suggested problems, our study is the first to systematically characterize this barrier."
It turns out it's quite common for pharmacies to block access.
"This study is the largest and most comprehensive pharmacy-focused assessment of buprenorphine availability to date and confirms that pharmacies can be a significant barrier to buprenorphine access nationwide," the authors write.
Four researchers called a total of 921 pharmacies around the country in May and June of 2020, focusing on 473 U.S. counties with high rates of death from opioid-related overdoses. Of all the pharmacies contacted, they found that 183 - 20% of the total - indicated they would not dispense buprenorphine. They found that independent pharmacies and those in southern U.S. states were significantly more likely to restrict buprenorphine.
Any disruption in access to buprenorphine can put a patient's recovery at serious risk.
"If I see a patient and they want to get started on buprenorphine, they've already gone through a lot of processing to make that behavior change," said co-author Ximena A. Levander, M.D., M.C.R., clinical instructor (general internal medicine and geriatrics) in the OHSU School of Medicine. "Any barrier can be very disruptive, especially when initiating treatment because they're at high risk to return to use."
Buprenorphine, approved by the Food and Drug Administration in 2002, relieves withdrawal symptoms and pain, and normalizes brain function by acting on the same targets in the brain as prescription opioids or heroin. It is one of three medicines approved by the FDA to treat opioid dependence, along with methadone and naltrexone.
Lead author Neda Kazerouni, a fourth-year student in the OHSU/OSU College of Pharmacy, said she hopes the research raises awareness of the stigma against people with opioid use disorder. As the nation's opioid epidemic continues to claim more than 70,000 lives annually in overdose deaths, Kazerouni said she hopes the new findings will encourage pharmacists to do their part to roll back the epidemic.
"Pharmacists can have a role in reducing opioid use disorder by reducing stigma," Kazerouni said. "Furthermore, community pharmacists should be encouraged to work collaboratively with a patient's provider to ensure there is continuity of care in all stages of treatment."
INFORMATION:
ELSE PRESS RELEASES FROM THIS DATE:
2021-04-26
A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a new rapid COVID-19 test.
A recent study published Nature Scientific Reports shows the novel method to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests.
"This test was made from the ground up," said Nam Tran, lead author for the study and a professor of pathology in the UC Davis School of Medicine. "Nothing like this test ever existed. We were starting with a clean slate."
The novel COVID-19 test uses an analytical instrument known as a mass spectrometer, which is paired with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. The mass spectrometer can analyze samples in minutes, with the ...
2021-04-26
PULLMAN, Wash. - Climate problems alone were not enough to end periods of ancient Pueblo development in the southwestern United States.
Drought is often blamed for the periodic disruptions of these Pueblo societies, but in a study with potential implications for the modern world, archaeologists have found evidence that slowly accumulating social tension likely played a substantial role in three dramatic upheavals in Pueblo development.
The findings, detailed in an article in the Proceedings of the National Academy of Sciences, showed that Pueblo farmers often persevered through droughts, but when social tensions were increasing, even modest droughts could spell the end of an era of ...
2021-04-26
The risk of childhood undernutrition varies widely among villages in India, according to new research led by Harvard T.H. Chan School of Public Health in collaboration with researchers at Harvard's Center for Geographic Analysis, Harvard's Center for Population and Development Studies, Korea University, Microsoft, and the Government of India.
The study is the first to predict and map the burden of childhood undernutrition across all of the nearly 600,000 villages in rural India, and the methods developed to do so could be applied to other health indicators and help advance the field of "precision public health," in which interventions and policies are tailored to smaller populations that are disproportionally ...
2021-04-26
One of the great mysteries of modern space science is neatly summed up by the view from NASA's Perseverance, which just landed on Mars: Today it's a desert planet, and yet the rover is sitting right next to an ancient river delta.
The apparent contradiction has puzzled scientists for decades, especially because at the same time that Mars had flowing rivers, it was getting less than a third as much sunshine as we enjoy today on Earth.
But a new study led by University of Chicago planetary scientist Edwin Kite, an assistant professor of geophysical sciences and an expert on climates of other worlds, uses a computer model to put forth a promising explanation: Mars ...
2021-04-26
Understanding spoken words, developing normal speech - cochlear implants enable people with profound hearing impairment to gain a great deal in terms of quality of life. However, background noises are problematic, they significantly compromise the comprehension of speech of people with cochlear implants. The team led by Tobias Moser from the Institute for Auditory Neuroscience and InnerEarLab at the University Medical Center Göttingen and from the Auditory Neuroscience and Optogenetics Laboratory at the German Primate Center - Leibniz Institute for Primate Research (DPZ) is therefore working to improve cochlear implants. The scientists want to use genetic engineering methods to make the nerve cells in the ear ...
2021-04-26
MADISON, Wis. -- In October of 2020, Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in chemistry for their discovery of an adaptable, easy way to edit genomes, known as CRISPR, which has transformed the world of genetic engineering.
CRISPR has been used to fight lung cancer and correct the mutation responsible for sickle cell anemia in stem cells. But the technology was also used by a Chinese scientist to secretly and illegally edit the genomes of twin girls -- the first-ever heritable mutation of the human germline made with genetic engineering.
"We've moved away from an era of science where we understood the risks that came with new technology and where decision stakes were ...
2021-04-26
New findings detailing the world's first-of-its-kind estimate of how many people live in high-altitude regions, will provide insight into future research of human physiology.
Dr. Joshua Tremblay, a postdoctoral fellow in UBC Okanagan's School of Health and Exercise Sciences, has released updated population estimates of how many people in the world live at a high altitude.
Historically the estimated number of people living at these elevations has varied widely. That's partially, he explains, because the definition of "high altitude" does not have a fixed cut-off.
Using novel techniques, Dr. Tremblay's publication in the Proceedings of the National ...
2021-04-26
New research reveals a genetic quirk in a small species of songbird in addition to its ability to carry a tune. It turns out the zebra finch is a surprisingly healthy bird.
A study published today in the journal Proceedings of the National Academy of Sciences reveals that zebra finches and other songbirds have a low-density lipoprotein receptor (LDLR) gene surprisingly different than other vertebrates.
The function of LDLR, which is responsible for cellular uptake of LDL-bound cholesterol, or "bad cholesterol," has been thought to be conserved across vertebrates. OHSU scientists found that in the case ...
2021-04-26
Stomata, formed by a pair of kidney-shaped guard cells, are tiny pores in leaves. They act like mouths that plants use to "eat" and "breathe." When they open, carbon dioxide (CO2) enters the plant for photosynthesis and oxygen (O2) is released into the atmosphere. At the same time as gases pass in and out, a great deal of water also evaporates through the same pores by way of transpiration.
These "mouths" close in response to environmental stimuli such as high CO2 levels, ozone, drought and microbe invasion. The protein responsible for closing these "mouths" is an anion channel, called SLAC1, which moves negatively charged ions across the guard cell membrane to reduce turgor pressure. Low pressure causes the guard cells to collapse and subsequently the stomatal pore to ...
2021-04-26
(Boston)--Lung carcinomas are the leading cause of cancer-related deaths in the United States and worldwide. Lung squamous cell carcinomas (non-small cell lung cancers that arise in the bronchi of the lungs and make up approximately 30 percent of all lung cancers) are poorly understood, particularly with respect to the cell type and signals that contribute to disease onset.
According to the researchers, treatments for lung squamous cell carcinomas are limited and research into the etiology of the disease is required to create new ways to treat it.
"Our study offers insight into how damage ...
LAST 30 PRESS RELEASES:
[Press-News.org] One in five pharmacies blocks access to key medication to treat addiction
New findings from the largest, most comprehensive study to date suggest opportunity to reduce stigma and roll back the national opioid epidemic
